Specialty Materials from Celanese for Medical Device Suppliers Showcased at DDL 26 Forum
Tue, December 8 2015
“Celanese has for years been a leading, global engineered materials
supplier to the medical device market,” said
Celanese will be showcasing its Hostaform® MT® SlideX™ POM product, a thermoplastic polymer that is an excellent low-friction solution for the following applications:
- pressurized Metered Dose Inhalers (pMDIs)
- dry powder inhalers
- spray pumps
“Studies show that patients are more likely to comply with medication regimens when using medical devices that are comfortable and easy to use,” said Johnson. “Celanese provides quality medical polymers to help our customers develop devices with patient needs in mind and improve the user experience.”
Celanese materials experts will be meeting with attendees at DDL 26 in booth 96 to discuss their latest project challenges and medical device innovations. For more information on Celanese Hostaform® MT® SlideX™ POM, visit http://celanese.com/webinars.
About Celanese
All registered trademarks are owned by
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures,
financing needs and other information that is not historical
information. When used in this release, the words “outlook,” “forecast,”
“estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,”
“believes,” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company or any of its
customers will realize these benefits or that these expectations will
prove correct. There are a number of risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements contained in this release. Numerous factors, many of which
are beyond the company’s control, could cause actual results to differ
materially from those expressed as forward-looking statements. Other
risk factors include those that are discussed in the company’s filings
with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20151208005170/en/
Celanese
Investor Relations:
chuck.kyrish@celanese.com
or
Media
Relations – Global:
william.jacobsen@celanese.com
or
Media
Relations Asia (
lan.zhang@celanese.com
or
Media
Relations Europe (
j.kurth@celanese.com
Source: